The global confocal microscope market is booming, projected to reach $1.8 billion by 2034. Driven by increased use in life sciences, materials science, and ophthalmology, along with R&D investment, North America is expected to lead this growth, reaching $580 million by 2034. Market competition is moderate, with key players focusing on innovation and market share gains.
The U.S. Fish and Wildlife Service (USFWS) has declined a petition by PETA and other groups to list long-tailed macaques (Macaca fascicularis) as endangered under the Endangered Species Act (ESA). The decision was made after the USFWS determined the petition lacked credible evidence supporting the need for such a listing, considering potential threats to the species. This decision aligns with recent findings by the National Association for Biomedical Research (NABR) that challenged the IUCN’s ‘Endangered’ designation for long-tailed macaques.
The global multiphoton microscopy market is expected to reach US$ 198.9 million in 2024 and continue growing at a CAGR of 5.5% through 2034, according to a recent report by Fact.MR. This growth is driven by the increasing use of multiphoton microscopy in various scientific fields, particularly in biomedical research where it offers high-resolution imaging of deep tissue structures with minimal damage. Advancements in technology, such as smaller, portable microscopes and the integration of artificial intelligence, are further boosting the market’s potential.
The global cell-based assays market is projected to reach US$ 40.4 billion by 2034, driven by increasing demand for drug development and biomedical research. Cell-based assays provide several advantages over traditional methods, offering a more accurate and physiologically relevant approach to analyzing drug properties. The market is segmented by product type, application, end user, and region, with North America leading the market due to significant drug discovery research and rising prevalence of chronic illnesses.
For the first time, scientists have successfully bred mice with fully functioning human immune systems. These ‘humanized’ mice can accurately mimic human immune responses, opening new avenues for drug development and testing vaccines without relying on human trials.
